You are here: Industry Insights > SARS-CoV-2

News List

Self-Contained, Rapid ADEXUSDx® COVID-19 Antibody Test Receives CE Mark americanpharmaceuticalreview
August 04, 2020
NOWDiagnostics has received Conformité Européene (CE) mark approval for its ADEXUSDx® COVID-19 antibody test for use in moderate/complex laboratory settings across 28 countries in the European Union (EU).
Experimental COVID-19 vaccine protects upper and lower airways in nonhuman primates worldpharmanews
July 30, 2020
Two doses of an experimental vaccine to prevent coronavirus disease 2019 (COVID-19) induced robust immune responses and rapidly controlled the coronavirus in the upper and lower airways of rhesus macaques exposed to SARS-CoV-2 ...
Immunoprotein impairs Sars-Cov-2 worldpharmanews
July 30, 2020
A protein produced by the human immune system can strongly inhibit corona viruses, including Sars-Cov-2, the pathogen causing Covid-19.
Ampio Starts Patient Enrollment in Ampion COVID-19 Program americanpharmaceuticalreview
July 30, 2020
Ampio Pharmaceuticals is actively working on the development of therapies for patients infected with the SARS-CoV-2 virus (COVID-19).
IDT Biologika Fills SARS-CoV-2 Vaccine Candidate contractpharma
July 30, 2020
IDT Biologika filled the second clinical batch of a newly-developed vaccine candidate against the coronavirus SARS-CoV-2 in Dessau.
Luminex Files EUA for Expanded NxTAG Respiratory Panel Test Including SARS-CoV-2 americanpharmaceuticalreview
July 29, 2020
Luminex has submitted an EUA request to the U.S. Food and Drug Administration (FDA) for a new expanded version of its NxTAG® Respiratory Pathogen Panel (RPP) to include the SARS-CoV-2 virus for high-throughput COVID-19 testing.
Pfizer and BioNTech select lead mRNA vaccine against COVID-19 pharmatimes
July 28, 2020
Pfizer and BioNTech have started a global Phase II/III safety and efficacy clinical study to evaluate a single nucleoside-modified messenger RNA (modRNA) candidate from their BNT162 mRNA-based vaccine programme against SARS-CoV-2.
Researchers say newly identified antibodies can neutralise SARS-CoV-2 pharmaceutical-technology
July 24, 2020
Researchers at Columbia University Irving Medical Center in the US have identified neutralising antibodies, isolated from Covid-19 patients, against the SARS-CoV-2 virus.
Just - Evotec Biologics Wins COVID-19 DoD Contract contractpharma
July 23, 2020
To develop and manufacture monoclonal antibodies (mAbs) for treatment and/or prevention of COVID-19.
UK’s SARS-CoV-2 vaccine candidate is safe and induces antibody and T cell response europeanpharmaceuticalreview
July 22, 2020
Data released from the Phase I/II trial of the ChAdOx1 COVID-19 vaccine candidate suggests it elicits an immune response with no adverse effects.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 61 62 Next page